2329 — Glory Health Industry Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$137.78m
- HK$26.31bn
- CNY3.90bn
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2,697 | 2,046 | 517 | 877 | -1,090 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -846 | -736 | -134 | -32.3 | 1,025 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,183 | 4,111 | 4,465 | 3,407 | 574 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 742 | 5,507 | 4,938 | 4,345 | 606 |
Capital Expenditures | -437 | -129 | -273 | -280 | -193 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 2,941 | -2,086 | -2,505 | 464 | -113 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 2,505 | -2,215 | -2,778 | 184 | -305 |
Financing Cash Flow Items | -1,094 | -1,803 | 535 | -3,094 | -220 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -3,808 | -3,785 | -1,113 | -5,654 | -631 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -561 | -493 | 1,048 | -1,125 | -330 |